Algenist®, the award-winning, anti-aging skincare brand featuring microalgae, one of the most nutrient-rich resources in the world, announced today its launch in Nordstrom locations throughout the United States. The launch into Nordstrom’s “Advanced Skincare” category marks an important retail milestone for the brand, furthering distribution for the line. The skincare line, developed by Solazyme, Inc. (NASDAQ: SZYM), a company commercializing renewable oils and other bioproducts, features two microalgae ingredients- Alguronic Acid® and Microalgae Oil. “Nordstrom offers a unique customer experience that provides the best possible service, selection, and quality to all of its shoppers. Their selection of luxury and high quality brands, coupled with their top-notch service, is unmatched in the industry, making Nordstrom the ideal place to experience a brand like Algenist,” stated Frederic Stoeckel, SVP & General Manager of Algenist. “Nordstrom is an exciting new step in Algenist’s expansion and we are thrilled to be partnering with them for this launch." Since the initial launch of the brand in 2011, Algenist has grown quickly in the U.S. and is now available in 15 countries worldwide throughout over 1400 retail locations. The line has won numerous awards, including the 2014 Marie Claire Prix d’ Excellence de la Beauté in France, and the QVC Rising Brand Star award, among others. Algenist will initially launch in multiple Nordstrom locations throughout the country, as well as on the retailer’s website. All products will retail between $25 and $110 and will be included in Nordstrom’s “Advanced Skincare” category. The entire Algenist line, which features over 25 products including the top-selling Genius Ultimate Anti-Aging Cream and Concentrated Reconstructing Serum, will initially be available in the Cosmetics department at select store locations. Follow Us Online:
Solazyme®, Algenist®, Alguronic Acid® and the Solazyme logo are registered trademarks of Solazyme, Inc.This press release contains certain forward-looking statements about Algenist and Solazyme, including statements that involve risks and uncertainties concerning: the number and location of stores participating in the launch; the price of the product; the attributes of the product; and the results achieved from product use. When used in this press release, the words “will”, “expects”, “intends” and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties. Potential risks and uncertainties include, among others: Algenist and Solazyme’s limited history in commercializing products; implementation risk in deploying new technologies and market acceptance of its products. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme. In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Annual Report on Form 10-K, as updated from time to time, for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme is not under any duty to update any of the information in this press release.